XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Share capital
Treasury Stock
Additional paid-in capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Equity - attributable to shareholders of Criteo S.A.
Non controlling interest
Beginning balance (in shares) at Dec. 31, 2018   67,708,203 (3,459,119)          
Beginning balance at Dec. 31, 2018 $ 967,891 $ 2,201 $ (79,159) $ 663,281 $ (30,522) $ 387,869 $ 943,670 $ 24,221
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 21,401         19,120 19,120 2,281
Other comprehensive income (loss) (11,545)       (11,347)   (11,347) (198)
Issuance of ordinary shares (in shares)   28,596            
Issuance of ordinary shares 373 $ 1   372     373  
Change in treasury stocks (in shares)   (1,594,288) 1,786,715          
Change in treasury stocks   $ (45) $ 40,080 (36,091)   (3,944)    
Share-Based Compensation 13,522     13,533     13,533 (11)
Other changes in equity 154     (1)   155 154  
Ending Balance (in shares) at Mar. 31, 2019   66,142,511 (1,672,404)          
Ending Balance at Mar. 31, 2019 991,796 $ 2,157 $ (39,079) 641,094 (41,869) 403,200 965,503 26,293
Beginning balance (in shares) at Dec. 31, 2018   67,708,203 (3,459,119)          
Beginning balance at Dec. 31, 2018 967,891 $ 2,201 $ (79,159) 663,281 (30,522) 387,869 943,670 24,221
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 33,938              
Other comprehensive income (loss) (2,532)              
Ending Balance (in shares) at Jun. 30, 2019   66,161,523 (1,118,969)          
Ending Balance at Jun. 30, 2019 1,024,963 $ 2,157 $ (26,564) 652,572 (33,293) 401,209 996,081 28,882
Beginning balance (in shares) at Mar. 31, 2019   66,142,511 (1,672,404)          
Beginning balance at Mar. 31, 2019 991,796 $ 2,157 $ (39,079) 641,094 (41,869) 403,200 965,503 26,293
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 12,537         10,823 10,823 1,714
Other comprehensive income (loss) 9,013       8,246   8,246 767
Issuance of ordinary shares (in shares)   19,012            
Issuance of ordinary shares 252     252     252  
Change in treasury stocks (in shares)     553,435          
Change in treasury stocks     $ 12,515     (12,515)    
Share-Based Compensation 11,362     11,254     11,254 108
Other changes in equity 3     (28) 330 (299) 3  
Ending Balance (in shares) at Jun. 30, 2019   66,161,523 (1,118,969)          
Ending Balance at Jun. 30, 2019 $ 1,024,963 $ 2,157 $ (26,564) 652,572 (33,293) 401,209 996,081 28,882
Beginning balance (in shares) at Dec. 31, 2019 66,197,181 66,197,181 (3,903,673)          
Beginning balance at Dec. 31, 2019 $ 1,037,988 $ 2,158 $ (74,900) 668,389 (40,105) 451,725 1,007,267 30,721
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 16,428         15,459 15,459 969
Other comprehensive income (loss) (14,198)       (14,178)   (14,178) (20)
Issuance of ordinary shares (in shares)   5,700            
Issuance of ordinary shares 39     39     39  
Change in treasury stocks (in shares)     (629,977)          
Change in treasury stocks (18,239)   $ (4,934)     (13,305) (18,239)  
Share-Based Compensation 8,131     8,082     8,082 49
Other changes in equity (3,541) [1]         (3,399) [1] (3,399) [1] (142)
Ending Balance (in shares) at Mar. 31, 2020   66,202,881 (4,533,650)          
Ending Balance at Mar. 31, 2020 $ 1,026,608 $ 2,158 $ (79,834) 676,510 (54,283) 450,480 995,031 31,577
Beginning balance (in shares) at Dec. 31, 2019 66,197,181 66,197,181 (3,903,673)          
Beginning balance at Dec. 31, 2019 $ 1,037,988 $ 2,158 $ (74,900) 668,389 (40,105) 451,725 1,007,267 30,721
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 22,578              
Other comprehensive income (loss) $ (3,971)              
Ending Balance (in shares) at Jun. 30, 2020 66,204,881 66,204,881 (5,589,408)          
Ending Balance at Jun. 30, 2020 $ 1,034,997 $ 2,158 $ (90,714) 683,288 (44,297) 452,247 1,002,682 32,315
Beginning balance (in shares) at Mar. 31, 2020   66,202,881 (4,533,650)          
Beginning balance at Mar. 31, 2020 1,026,608 $ 2,158 $ (79,834) 676,510 (54,283) 450,480 995,031 31,577
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 6,150         5,716 5,716 434
Other comprehensive income (loss) 10,227       9,986   9,986 241
Issuance of ordinary shares (in shares)   2,000            
Issuance of ordinary shares 13     13     13  
Change in treasury stocks (in shares)     (1,055,758)          
Change in treasury stocks (14,861)   $ (10,880)     (3,981) (14,861)  
Share-Based Compensation 6,804     6,765     6,765 39
Other changes in equity $ 56         32 32 24
Ending Balance (in shares) at Jun. 30, 2020 66,204,881 66,204,881 (5,589,408)          
Ending Balance at Jun. 30, 2020 $ 1,034,997 $ 2,158 $ (90,714) $ 683,288 $ (44,297) $ 452,247 $ 1,002,682 $ 32,315
[1] From January 1, 2020, we adopted ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost issued by the Financial Accounting Standards Board (FASB).